Company: MYSEW
Filing Date: 2025-01-08
Form Type: 424B5
Source: 0001213900-25-002125
Chunk: 11

Company: Myseum, Inc.
Filing Date: 2025-01-08
Form: 424B5
Chunk 11
---
 website address is www.datchat.com. The information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our securities.

<div align='center'>S-5</div>

THE OFFERING

| Common Stock Offered by Us                                     |     | 1,200,000 shares.                                                                                                                       |
| Offering Price                                                 |     | $4.25                                                                                                                                   
 per share.                                                                                                                              |
| Common Stock to be Outstanding Immediately Before the Offering |     | 3,009,329 shares                                                                                                                        |
| Common Stock to be Outstanding Immediately After this          
 Offering (1)                                                   |     | 4,209,329 shares (excluding                                                                                                             
 shares of common stock issuable upon exercise of the Placement Agent Warrants).                                                         |
| Use of Proceeds                                                |     | The net proceeds from our                                                                                                               
 sale of securities in this offering will be approximately $4.53 million, after deducting Placement Agent fees and other estimated       
 offering expenses payable by us. We intend to use the net proceeds to us from this offering for general corporate and working           
 capital purposes. See “Use of Proceeds.”                                                                                                |
| Risk Factors                                                   |     | Investing in our securities                                                                                                             
 involves a high degree of risk. You should read the “Risk Factors” section beginning on page S-7 of this prospectus supplement          
 and page 7 of the accompanying prospectus and in the documents incorporated by reference in this prospectus supplement for a discussion 
 of factors to consider before deciding to invest in our securities.                                                                     |
| Nasdaq Capital Market symbol                                   |     | “DATS”.                                                                                                                                 |

The number of shares of our common stock outstanding before this offering and to be outstanding immediately after this offering is based on 3,009,329 shares of our common stock issued and outstanding as of January 7, 2025, and excludes the following:

| ● | 140,750 shares of our common stock issuable upon the exercise of stock options outstanding under our 2021 Omnibus Equity Incentive Plan as of September 30, 2024, at a weighted-average exercise price of $114.65 per share; |

| ● | 459,430 shares of common stock reserved for future issuance under our 2021 Omnibus Equity Incentive Plan; and |

| ● | 67,385 shares of our common